Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
15 participants
INTERVENTIONAL
2014-12-31
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Exploring Cortical Remyelination in Children With Multiple Sclerosis
NCT05258396
Understanding Magnetic Resonance Imaging in Multiple Sclerosis
NCT03872583
Ultra-high-field Brain MRI in Multiple Sclerosis
NCT05718947
Study of the Effect of BG00012 on MRI Lesions and Pharmacokinetics in Pediatric Subjects With RRMS
NCT02410200
A Multicenter Observational Study to Evaluate Pediatric Multiple Sclerosis in Brazil
NCT03087136
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Besides MRI-DTI several clinical data are recorded every 6 months:
1. expanded disability status scale (EDSS)
2. disease activity/ relapse rate
3. lesion load (number of T2-lesions)
4. brain atrophy
5. visual and somatosensoric evoked potentials (VEP, SSEP)
6. neuropsychological examination
Furthermore a complete neurological examination is done every 6 months and particular medication of each patient is recorded in a specific investigator form (case report form, CRF)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
DTI-MRI
MRI of the brain with specific DTI-sequences according to a specific investigation protocol
DTI-MRI
MRI of the brain with special DTI-sequences are performed in each child with multiple sclerosis or clinically isolated syndrome at timepoint of first manifestation and every 6 months in a longterm follow-up of 3 years
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
DTI-MRI
MRI of the brain with special DTI-sequences are performed in each child with multiple sclerosis or clinically isolated syndrome at timepoint of first manifestation and every 6 months in a longterm follow-up of 3 years
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* diagnosis of multiple sclerosis (MS) according to the McDonald criteria 2010 and the consensus recommendations of International Pediatric MS Study Group (IPMSSG) (Krupp et al 2013)
* diagnosis of CIS according to the consensus recommendation of IPMSSG (Krupp et al 2013)
* all types of medication/therapy
Exclusion Criteria
* claustrophobia
* allergic reaction of gadolinium (contrast medium)
* implantation of cardiac device
* implantation of neurostimulators
* implantation of cochlea implants
* presence of tattooing (over 20% of body surface)
* presence of permanent-make-up
* presence of permanent transdermal patches
* presence of special catheter systems with temperature probes which cannot be removed
* implantation of metalliferous implants or implants which could contain metal traces
* implantation of artificial heart valves
* implantation of stents or coils
* presence of metal fragments in the eyes
5 Years
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Muenster
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christiane Elpers, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital Muenster
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Muenster
Münster, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2014-490-f-S
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.